Lawmakers press genetic testing companies for details on their privacy policies
By Megan Thielking,
Stat News
| 06. 21. 2018
Pressure is growing on direct-to-consumer genealogy and genetic testing companies to be more transparent about their privacy policies, after the arrest of the notorious Golden State Killer using publicly available data from one of the websites.
In a letter sent this week — and shared with STAT — Reps. Dave Loebsack of Iowa and Frank Pallone Jr. of New Jersey peppered four of the platforms with questions about their security systems and customer privacy. The Democratic lawmakers are hoping to work with the companies — 23andMe, AncestryDNA, Family Tree DNA, and National Geographic Geno — to identify and resolve any privacy and security issues. And they’re in a prime position to do so: They sit on the Energy and Commerce committee, which handles both health care and privacy issues in technology.
“Much more often than not, Congress acts after the horse is out of the barn,” Loebsack said. “I want to try to partner with genetic testing services to address any potential challenges before there are actually breaches of trust.”
Genetic testing and genealogy platforms have come under fresh scrutiny...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...